ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
31
Frequently Asked Questions
What is Market Cap of Obalon Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Obalon Therapeutics Inc market cap is $3.98M.
What is the 52-week high for Obalon Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Obalon Therapeutics Inc 52 week high is $2.80 as of September 17, 2025.
What is the 52-week low for Obalon Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Obalon Therapeutics Inc 52 week low is $0.1414 as of September 17, 2025.
What is Obalon Therapeutics Inc stock price today?
Obalon Therapeutics Inc stock price today is $0.1635.
What was Obalon Therapeutics Inc stock price yesterday?
Obalon Therapeutics Inc stock price yesterday was $0.1698.
What is the PE ratio of Obalon Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Obalon Therapeutics Inc’s P/E ratio is -0.05.
What is the Price-to-Book ratio of Obalon Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Obalon Therapeutics Inc P/B ratio is 0.5978.
What is Obalon Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Obalon Therapeutics Inc's EBITDA is -0.11.
What is the 50-day moving average of Obalon Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Obalon Therapeutics Inc 50-day moving average is $0.1689.
How many employess does Obalon Therapeutics Inc has?